Product Information
HYDROXYZINE HCL 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0356 per EA under NDC 16571011410. Its NADAC has been published 113 times since May 1, 2024.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571011410
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217652On Market Since
8/22/2023
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE HCL 25 MG TABLET has been published 113 times since May 1, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0356 per EA |
|---|---|
| All-time high | $0.0469 (Nov 13, 2024) |
| All-time low | $0.0341 (Nov 20, 2024) |
| 52-week high | $0.0401 |
| 52-week low | $0.0346 |
| Median price | $0.0370 |
| Average price | $0.0386 |
| Largest weekly change | -27.4% (Nov 20, 2024) |
| Weeks tracked | 113 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROXYZINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE HCL 25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0356 per EA (NDC 16571011410), effective Jun 24, 2026.
How has the price of HYDROXYZINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE HCL 25 MG TABLET has held within roughly two percent of its current level. It has been tracked across 113 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE HCL 25 MG TABLET?
Since May 1, 2024, the NADAC for HYDROXYZINE HCL 25 MG TABLET has ranged from a low of $0.0341 (Nov 20, 2024) to a high of $0.0469 (Nov 13, 2024), with a median of $0.0370 per EA.
Are there cheaper alternatives to HYDROXYZINE HCL 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as HYDROXYZINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures HYDROXYZINE HCL 25 MG TABLET?
HYDROXYZINE HCL 25 MG TABLET (NDC 16571011410) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification